Comgest Growth Europe EUR I Fixed IncRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 17.5 | 27.0 | -15.7 | 20.9 | 4.2 | |
+/-Cat | 2.9 | 10.2 | 0.3 | 7.5 | 0.7 | |
+/-B’mrk | - | - | - | 7.4 | -1.6 | |
Category: Europe Large-Cap Growth Equity | ||||||
Category Benchmark: Morningstar DM Europe Grt T... |
Key Stats | ||
NAV 03/05/2024 | EUR 37.99 | |
Day Change | 1.07% | |
Morningstar Category™ | Europe Large-Cap Growth Equity | |
ISIN | IE00BGPZCL61 | |
Fund Size (Mil) 03/05/2024 | EUR 6249.05 | |
Share Class Size (Mil) 03/05/2024 | EUR 35.04 | |
Max Initial Charge | - | |
Ongoing Charge 20/02/2023 | 1.05% |
Morningstar Research |
Analyst Report | 20/09/2023 Mathieu Caquineau, Director Morningstar, Inc |
Comgest Growth Europe’s strong and cohesive team and its time-tested growth strategy make it an outstanding choice for investors. The strategy earns People and Process pillar ratings of High. As a result, the Ireland-domiciled fund’s I and clean... | |
Click here to read this analyst report on the underlying fund. |
Morningstar Pillars | |
---|---|
People | 25 |
Parent | 24 |
Process | 25 |
Performance | |
Price |
Investment Objective: Comgest Growth Europe EUR I Fixed Inc |
The investment objective of the Fund is to create a professionally managed portfolio consisting of what, in the opinion of the Investment Manager, are high quality long-term growth companies having their headquarters or carrying out their predominant activities in Europe. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Franz Weis 01/11/2009 | ||
Pierre Lamelin 28/02/2022 | ||
Click here to see others | ||
Inception Date 03/07/2019 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | Morningstar DM Europe Grt TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Comgest Growth Europe EUR I Fixed Inc | 31/01/2024 |
|
|
Top 5 Holdings | Sector | % |
ASML Holding NV | Technology | 8.88 |
Novo Nordisk A/S Class B | Healthcare | 8.48 |
Accenture PLC Class A | Technology | 4.80 |
Essilorluxottica | Healthcare | 4.60 |
Experian PLC | Industrials | 4.18 |
Increase Decrease New since last portfolio | ||
Comgest Growth Europe EUR I Fixed Inc |